Dow Down 0.69% Nasdaq Down 0.89%

Clovis Oncology, Inc. (CLVS)

-NasdaqGS
14.31 Down 0.23(1.56%) 2:44PM EDT - Nasdaq Real Time Price
Prev Close:14.54
Open:14.26
Bid:14.32 x 200
Ask:14.36 x 200
1y Target Est:20.50
Beta:1.24532
Next Earnings Date: 5-May-16CLVS Earnings announcement
Day's Range:13.91 - 14.57
52wk Range:12.25 - 116.75
Volume:269,275
Avg Vol (3m):1,433,390
Market Cap:549.02M
P/E (ttm):N/A
EPS (ttm):-9.80
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
CLVSDown 1.56%549.02M
IMMUUp 0.54%350.54M
THLDDown 2.25%30.76M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-8.60
Quarterly EPS Est (Mar-16) :-2.39
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback